Mr. Speaker, I thank the parliamentary secretary for staying here during adjournment proceedings to respond to my question. However, I do not think that her response has addressed the question I am asking.
We know about the work and funding for vaccines. However, the antibody treatment is a different treatment. I am asking whether the government is going to fund some sort of work in Canada to manufacture the monoclonal antibodies for Ebola.